Update date: Jul 08, 2026 | 100 Pages | Report ID: HO-003710
Passive Motion Devices Market
DMA IntelligenceHow Big Is the Passive Motion Devices Market? Size, Share & Forecast 2033
Segments: Type (Knee Joint CPM Devices, Shoulder Joint CPM Devices, Hip Joint CPM Devices, Ankle Joint CPM Devices, Others), Design (Portable Devices, Fixed Devices), Demographics (Children (Below 18), Adult (18 and above)), By Region, And Segment Forecasts
$541.1M
Market Size, 2025
$580.3M
Market Estimate, 2026
$947.2M
Market Forecast, 2033
7.3%
CAGR, 2026–2033
Passive Motion Devices Market Size, Share & Key Insights
The Passive Motion Devices Market size was valued at USD 541.10 Million in 2025, and the market is projected to grow from USD 580.33 Million in 2026 to USD 947.23 Million by 2033, growing at a CAGR of 7.25% during the forecast period 2026–2033. The market saw distributed global demand in 2025.
Study Overview
 Study Period | 2021 - 2033 |
 Base Year | 2025 |
 Estimated Year | 2026 |
 Forecast Period | 2026-2033 |
 Historical Range | 2021-2025 |
| Units | USD Million |
 Coverage | Global | North America, Europe, Asia-Pacific, Latin America, Middle East & Africa |
 Deliverables | PDF + Excel Data Pack |
Major Market Players
Key Insights
- The global Passive Motion Devices market is projected to grow from USD 541.10 Million in 2025 to USD 946.06 Million by 2033, demonstrating a robust CAGR of 7.25% over the forecast period.
- North America dominated the market in 2025, holding the largest share due to advanced healthcare infrastructure and high adoption of rehabilitation therapies, while Asia Pacific is anticipated to be the fastest-growing region.
- Continuous Passive Motion (CPM) Devices are expected to maintain their lead in the market, driven by their proven efficacy in post-operative joint recovery and widespread clinical acceptance.
Market Definition and Strategic Context
The Passive Motion Devices Market refers to the global industry encompassing the design, development, manufacturing, and distribution of medical devices that provide continuous passive motion (CPM) to joints, primarily used in rehabilitation and post-operative recovery. These devices are crucial for improving range of motion, reducing stiffness, preventing complications like adhesions, and accelerating healing after orthopedic surgeries or injuries. The market's relevance stems from the increasing prevalence of orthopedic conditions, sports injuries, and an aging global population requiring effective rehabilitation solutions. The market is characterized by technological advancements aimed at enhancing patient comfort, device portability, and therapeutic efficacy. Key applications include knee, shoulder, and elbow rehabilitation, among others. The Passive Motion Devices market size was valued at USD 541.10 Million in 2025 and is projected to exhibit robust growth outlook, driven by expanding healthcare infrastructure, rising awareness about rehabilitation, and the integration of smart technologies in medical devices. The industry expansion is further propelled by a growing number of surgical procedures and the demand for non-invasive recovery methods. This comprehensive market forecast provides an in-depth analysis of segment performance, regional dynamics, competitive landscape, and future growth trajectories, empowering stakeholders with critical insights for strategic decision-making. The evolving landscape of orthopedic care, coupled with a focus on patient-centric recovery, underpins the sustained growth of this vital medical device sector. The market's trajectory is also influenced by reimbursement policies and regulatory frameworks that shape product accessibility and adoption rates across various geographies.
| Report Attribute | Details |
|---|---|
| Market size value in 2025 | USD 541.10 Million |
| Revenue forecast in 2033 | USD 947.23 Million |
| Growth rate | CAGR of 7.25% from 2025 to 2033 |
| Actual data | 2021 - 2024 |
| Forecast period | 2025 - 2033 |
| Quantitative units | Revenue in USD Million and CAGR from 2025 to 2033 |
| Report coverage | Revenue forecast, company share, competitive landscape, growth factors, and trends |
| Segments covered | Type, Design, Demographics |
| Regional scope | North America; Europe; Asia Pacific; Latin America; Middle East and Africa (MEA) |
| Country scope | U.S.; Canada; Mexico; Germany; UK; France; Italy; Spain; Denmark; Sweden; Norway; China; Japan; India; Australia; South Korea; Thailand; Brazil; Argentina; South Africa; Saudi Arabia; UAE; Kuwait |
| Key companies profiled | The Furniss Corporation Ltd; Surgi-Care, Inc; Bio-Med International Pvt Ltd; CHINESPORT Spa Cap. (Chinesport Rehabilitation); BTL Corporate; Chattanooga (DJO, LLC); Biodex; Kinetec UK; Kinex Medical Company, LLC; HMS Medical Systems |
| Customization scope | Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
| Pricing and purchase options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
Growth Catalysts & Market Constraints
The Passive Motion Devices market dynamics are shaped by a confluence of factors, including an aging global population, increasing incidence of orthopedic injuries, and advancements in rehabilitation technology. The market is experiencing sustained growth due to the rising number of surgical procedures that necessitate post-operative passive motion therapy for optimal recovery. This demand is further amplified by growing awareness among healthcare professionals and patients about the benefits of early and consistent rehabilitation. The Passive Motion Devices market size continues to expand as device manufacturers innovate to provide more portable, user-friendly, and technologically integrated solutions. However, challenges related to high equipment costs, limited reimbursement policies in some regions, and the need for specialized training for device operation can temper the overall growth forecast. Understanding these multifaceted drivers and restraints is crucial for navigating the industry's trajectory and capitalizing on emerging opportunities in this evolving healthcare segment.
Growth Drivers
- Increasing prevalence of orthopedic conditions and sports injuries significantly drives the demand for passive motion devices. As the global population ages and participation in high-impact sports rises, the incidence of joint injuries and degenerative diseases escalates, necessitating effective rehabilitation tools to restore mobility and function, thereby boosting market growth.
- Advancements in rehabilitation technology and growing awareness about the benefits of early post-operative mobilization are key drivers. Innovations leading to more portable, user-friendly, and digitally integrated passive motion devices enhance patient compliance and therapeutic outcomes, while increased education among clinicians and patients fosters greater adoption.
Restraints
- High cost of passive motion devices and limited reimbursement policies in certain regions pose a significant restraint on market expansion. The initial investment required for these specialized medical devices can be prohibitive for smaller clinics or individual patients, and inadequate insurance coverage reduces accessibility and adoption rates.
- Lack of skilled professionals to operate and maintain advanced passive motion devices presents a challenge. Proper utilization of these devices requires specific training and expertise, and a shortage of such qualified personnel can limit their effective deployment, particularly in developing healthcare systems.
Opportunities
- Expansion into emerging markets offers substantial growth opportunities due to developing healthcare infrastructures and rising disposable incomes. Countries in Asia Pacific and Latin America are investing in modernizing their medical facilities, creating fertile ground for market penetration and increased adoption of advanced rehabilitation equipment.
- Technological integration, such as smart features, IoT connectivity, and personalized therapy programs, presents a significant opportunity. Developing devices that offer real-time data tracking, remote monitoring, and customizable treatment protocols can enhance patient engagement and improve therapeutic efficiency, opening new avenues for innovation.
Challenges
- Intense competition and price sensitivity in the market can lead to margin pressures for manufacturers. The presence of numerous players offering similar products forces companies to engage in aggressive pricing strategies, making it difficult to maintain profitability, especially for new entrants.
- Regulatory hurdles and the need for stringent clinical validation pose challenges for product development and market entry. Obtaining necessary approvals and demonstrating clinical efficacy through rigorous trials can be time-consuming and expensive, delaying product launches and increasing operational costs.
Market Level Breakdown
The Passive Motion Devices market is segmented by Type into Continuous Passive Motion (CPM) Devices, Semi-Continuous Passive Motion (SCPM) Devices, and Intermittent Passive Motion (IPM) Devices. CPM devices represent the largest share of the market, primarily due to their long-standing clinical acceptance and proven efficacy in accelerating post-operative recovery, particularly for knee and shoulder surgeries. These devices provide gentle, repetitive motion without active muscle involvement, crucial for preventing joint stiffness and promoting cartilage healing. SCPM and IPM devices, while offering specialized applications, cater to niche requirements, contributing to the overall market's diversity and addressing varied patient needs in rehabilitation.
Segmentation by Design categorizes the market into Portable Devices and Stationary Devices. Portable devices are gaining significant traction, holding a larger market share, driven by the increasing demand for home-based rehabilitation and greater patient convenience. Their lightweight and compact nature allows for easier transport and use in various settings, enhancing patient compliance and accessibility to therapy. Stationary devices, typically found in hospitals and rehabilitation centers, offer robust functionality and are often used for more intensive or supervised therapy sessions, contributing a substantial portion to the Passive Motion Devices market size.
Further segmentation by Demographics includes Adults and Pediatrics. The adult segment dominates the market due to the higher incidence of age-related orthopedic conditions, degenerative joint diseases, and sports injuries in this population group. Passive motion devices are extensively used in adult rehabilitation following joint replacement surgeries or significant musculoskeletal trauma. While the pediatric segment is smaller, there is a growing recognition of the importance of early intervention for congenital conditions or injuries in children, driving specialized device development and contributing to the overall Passive Motion Devices segmentation and growth outlook.
Passive Motion Devices Segmentation Breakdown
- Type
- Knee Joint CPM Devices
- Shoulder Joint CPM Devices
- Hip Joint CPM Devices
- Ankle Joint CPM Devices
- Others
- Design
- Portable Devices
- Fixed Devices
- Demographics
- Children (Below 18)
- Adult (18 and above)
Geographic Performance & Regional Trends
Geographically, the Passive Motion Devices market exhibits significant variations in adoption and growth. North America emerged as the largest market in 2025, primarily due to its advanced healthcare infrastructure, high healthcare expenditure, and a well-established reimbursement system for rehabilitation therapies. The presence of leading market players and increasing awareness regarding post-operative care further solidify its dominant position. Conversely, Asia Pacific is projected to be the fastest-growing region, driven by rapidly developing economies, improving healthcare access, a large patient pool, and increasing medical tourism. This regional forecast underscores the shift in market dynamics as emerging economies invest heavily in healthcare modernization and expand their rehabilitation services.
Regional Growth Drivers
- North America: The region benefits from a robust healthcare system, high rates of orthopedic surgeries, and a strong emphasis on post-operative rehabilitation. The presence of key market players and favorable reimbursement policies for passive motion therapy in countries like the U.S. and Canada significantly drive market growth and product innovation.
- Europe: Advanced medical technologies and high healthcare spending contribute to market growth in Europe. Strict regulatory standards ensure product quality and safety, while increasing adoption of minimally invasive surgeries, especially in countries like Germany, the United Kingdom, and France, fuels the demand for effective rehabilitation devices.
- Asia Pacific: This region is characterized by rapid economic development, improving healthcare infrastructure, and a large patient population, particularly in countries like China, Japan, and India. Growing medical tourism, rising disposable incomes, and increasing awareness about rehabilitation therapies are accelerating market expansion.
- Latin America: Modernization of healthcare facilities and increasing investment in medical infrastructure are key drivers in Latin America. Growing prevalence of chronic diseases and sports injuries, coupled with efforts to enhance patient access to advanced medical treatments in countries like Brazil and Mexico, are boosting market demand.
- Middle East & Africa: Enhanced access to quality healthcare and increasing government initiatives to upgrade medical services are propelling market growth in MEA. The rising incidence of lifestyle-related disorders and trauma, alongside growing healthcare expenditure in countries like Saudi Arabia and South Africa, supports the adoption of passive motion devices.
The regional landscape for Passive Motion Devices indicates a divergence between mature and emerging markets. While North America and Europe will continue to be significant revenue contributors due to established healthcare systems and high adoption rates, the fastest growth will emanate from Asia Pacific, Latin America, and MEA. This shift presents strategic implications for suppliers, necessitating localized market penetration strategies, adaptation to diverse regulatory environments, and investment in distribution networks in these high-growth regions. The long-term regional forecast suggests a more balanced global distribution of market share, driven by increasing globalization of healthcare and rising standards of living worldwide.
Competitive Insights & Leading Companies
The Passive Motion Devices competitive landscape is characterized by a moderately consolidated structure, with several established global players alongside a growing number of regional and specialized manufacturers. Key companies differentiate themselves through product innovation, technological advancements, and strategic partnerships. The market sees a mix of large medical device conglomerates and niche players focusing on specific joint rehabilitation. Competitive levers include the development of ergonomic and portable devices, integration of smart features for personalized therapy, and securing regulatory approvals and certifications across various geographies. Pricing strategies remain a critical factor, balancing affordability with advanced functionality, especially in regions with varying healthcare budgets. Distribution networks, encompassing direct sales, distributors, and online channels, are crucial for market reach and customer engagement. The emphasis on clinical efficacy and patient outcomes drives continuous research and development efforts, ensuring that devices meet evolving clinical needs and improve recovery processes. Companies strive to build strong brand recognition and cultivate relationships with orthopedic surgeons, physical therapists, and rehabilitation centers to maintain their market position in the Passive Motion Devices competitive landscape.
Leading companies in the Passive Motion Devices market employ diverse strategies to sustain growth and enhance their market presence. These include mergers and acquisitions to expand product portfolios and geographical reach, strategic partnerships for technology sharing and market penetration, and consistent product launches featuring enhanced patient comfort and digital integration. For instance, some players focus on developing highly specialized devices for specific joint applications, while others invest in creating comprehensive rehabilitation solutions. Differentiation often stems from superior technology, such as advanced motor control for smoother motion, lightweight materials for portability, or intuitive user interfaces. Strong service models, including training and technical support, also play a vital role in customer retention. Challenges such as margin pressure due to intense competition and the high cost of R&D for innovative features compel companies to optimize their operational efficiencies. Furthermore, navigating complex supply chain risks and ensuring compliance with evolving medical device regulations are critical for long-term success. Localization of products and services to cater to regional preferences and healthcare systems also forms a key part of their strategic approach to capture a larger share of the Passive Motion Devices market.
Passive Motion Devices Key Companies
- The Furniss Corporation Ltd
- Surgi-Care, Inc
- Bio-Med International Pvt Ltd
- CHINESPORT Spa Cap. (Chinesport Rehabilitation)
- BTL Corporate
- Chattanooga (DJO, LLC)
- Biodex
- Kinetec UK
- Kinex Medical Company, LLC
- HMS Medical Systems
Passive Motion Devices Market Ecosystem
Ecosystem Participants
- Device Manufacturers — These companies are at the core of the ecosystem, responsible for the research, design, development, manufacturing, and commercialization of various passive motion devices. They focus on innovation, quality control, and regulatory compliance to produce effective and safe rehabilitation tools, constantly striving to integrate new technologies for improved patient outcomes and device functionality.
- Their operational responsibilities include sourcing raw materials, assembly, testing, and packaging. Key challenges involve managing complex supply chains, adhering to stringent medical device regulations, and investing heavily in R&D to stay competitive. They collaborate with healthcare providers to understand clinical needs and tailor solutions.
- Healthcare Providers — This segment includes hospitals, rehabilitation centers, physical therapy clinics, and orthopedic specialists who purchase and utilize passive motion devices for patient treatment. They are the primary end-users, delivering therapy to patients recovering from surgeries, injuries, or suffering from chronic joint conditions. Their role is critical in driving adoption and providing feedback for product improvements.
- Healthcare providers are responsible for patient assessment, therapy prescription, device operation, and monitoring patient progress. Their buying decisions are influenced by clinical effectiveness, cost-efficiency, ease of use, and compatibility with existing infrastructure. They often collaborate with manufacturers for training and support.
- Distributors and Suppliers — These entities act as intermediaries between manufacturers and healthcare providers, facilitating the sales, marketing, and logistics of passive motion devices. They play a crucial role in ensuring market reach, particularly in fragmented or geographically diverse markets, and often provide local support and maintenance services.
- Their operational responsibilities include inventory management, regional sales strategies, customer service, and technical support. They face challenges in maintaining broad product portfolios and managing intricate logistics. Collaborations with manufacturers are essential for exclusive distribution rights and market access.
- Research and Academic Institutions — These organizations contribute to the ecosystem through fundamental research, clinical trials, and educational programs related to passive motion therapy and device efficacy. They often partner with manufacturers to validate new technologies and develop evidence-based treatment protocols, shaping future innovations and clinical guidelines.
- Their role involves generating scientific evidence, informing best practices, and training the next generation of healthcare professionals. They influence market trends by publishing studies on device effectiveness and safety. Funding for research often comes from grants, government bodies, and industry partnerships.
- Regulatory Bodies and Government Agencies — These entities are responsible for establishing and enforcing regulations, standards, and guidelines for the manufacturing, marketing, and use of medical devices. Their oversight ensures patient safety, device quality, and ethical conduct within the industry, impacting product development cycles and market entry strategies.
- Their responsibilities include product approval, post-market surveillance, and policy formulation. Compliance with regulations like FDA (U.S.), CE Mark (Europe), and other national standards is paramount for manufacturers. They interact with all ecosystem players to maintain a safe and effective market environment.
Report Coverage & Key Deliverables
The report delivers a comprehensive analysis of the Passive Motion Devices, combining quantitative data with qualitative insights. It is meticulously designed to provide stakeholders with an in-depth understanding of market dynamics, competitive landscape, and future growth opportunities. This detailed assessment helps businesses, investors, and healthcare professionals make informed strategic decisions. The report covers historical market performance, current trends, and a robust forecast, enabling users to identify key growth segments and emerging regions. It dissects the market by various parameters, offering granular insights into product types, applications, and regional consumption patterns. Furthermore, it includes profiles of leading companies, highlighting their strategies, product portfolios, and recent developments. The comprehensive nature of this report ensures that readers gain a holistic view of the Passive Motion Devices market, facilitating effective market entry, expansion, and investment planning. It serves as an invaluable resource for anyone seeking to navigate the complexities of this evolving medical device sector and capitalize on its significant potential.
Report Coverage
- Market Size Estimates (historical and forecast)
- This section provides precise market size figures, covering historical data from 2021 to 2025 and a comprehensive forecast extending from 2026 to 2033. Our methodology employs a rigorous combination of top-down and bottom-up approaches, integrating primary and secondary research to ensure accuracy and reliability in revenue projections.
- Detailed Segmentation And Revenue Analysis
- The report offers an exhaustive breakdown of the market by type, design, and demographics. Each segment is analyzed for its revenue contribution, growth trajectory, and market share, providing a clear understanding of the most lucrative and fastest-growing sub-markets. This granular view helps identify key investment areas.
- Regional And Country-Level Insights
- An in-depth analysis of the Passive Motion Devices market across major regions (North America, Europe, Asia Pacific, Latin America, MEA) and key countries is included. This section highlights regional market maturity, growth drivers, and challenges, offering strategic perspectives on geographic expansion and market penetration opportunities.
- Competitive Benchmarking Of Key Players
- This part of the report profiles leading market participants, assessing their product portfolios, strategic initiatives, market positioning, and recent developments. It provides a competitive landscape overview, enabling stakeholders to understand key differentiators, market concentration, and strategic alliances within the industry.
- Customization Options Based on Specific Requirements
- We offer flexible customization options, allowing clients to tailor the report's scope to their specific needs. This includes adding or altering country, regional, and segment analyses, providing deeper dives into particular product categories, or conducting targeted competitive assessments to meet unique business intelligence requirements.
Recent Industry Insights
The Passive Motion Devices industry trends have seen notable developments over the last 12-18 months, driven by a focus on patient-centric care and technological integration. There's been a clear push towards developing more portable and user-friendly devices, allowing for greater adoption in home-based rehabilitation settings. Strategic partnerships between device manufacturers and healthcare technology companies have become more common, aiming to integrate smart features like AI-powered analytics and remote monitoring capabilities. Regulatory bodies continue to emphasize stringent clinical validation and post-market surveillance, ensuring device safety and efficacy. Shifts in consumer preferences towards non-invasive and accelerated recovery methods are also influencing product design and marketing strategies. Furthermore, some companies have expanded their manufacturing capacities or distribution networks to address rising global demand, particularly in emerging markets, indicating a robust and evolving Passive Motion Devices industry.
Key Market Developments
- August 2024: Kinetec UK launched a new line of lightweight and portable CPM devices designed for enhanced patient mobility and ease of use in home rehabilitation settings.
- May 2024: Chattanooga (DJO, LLC) announced a strategic partnership with a leading telemedicine platform to integrate remote monitoring capabilities into their passive motion therapy solutions, expanding patient access to supervised recovery.
- February 2024: The Furniss Corporation Ltd received expanded regulatory approval in several European countries for their advanced knee CPM device, allowing for broader market penetration.
- November 2023: Bio-Med International Pvt Ltd invested in upgrading its manufacturing facility in India to increase production capacity for its range of rehabilitation equipment, including passive motion devices, to meet rising regional demand.
- September 2023: Biodex introduced a new software update for its passive motion systems, offering personalized therapy protocols and improved data analytics for clinicians.
Analyst Opinion
The Passive Motion Devices market outlook remains highly positive, driven by an undeniable demographic shift towards an aging global population and a continuous rise in orthopedic surgeries. The market's attractiveness stems from the essential role these devices play in post-operative recovery, significantly improving patient outcomes and reducing rehabilitation times. While the competitive intensity is moderately consolidated, innovation remains a key differentiator. Companies that invest in ergonomic design, portability, and smart technology integration are poised for significant gains. The demand-supply balance is currently stable, but localized surges in demand, particularly in emerging economies with expanding healthcare infrastructures, could create opportunities for agile manufacturers. The increasing awareness among patients and healthcare providers about the long-term benefits of early and consistent passive motion therapy further solidifies the market's robust growth trajectory, making it an appealing segment for both established players and new entrants with specialized solutions.
Looking ahead, the long-term outlook for the Passive Motion Devices market is characterized by sustained growth, underpinned by technological advancements and expanding clinical applications. Innovations are expected to focus on incorporating artificial intelligence for predictive analytics, virtual reality for engaging patient experiences, and advanced materials for lighter, more comfortable devices. Key risk factors include the high cost of R&D, potential reimbursement challenges in certain healthcare systems, and the need for continuous regulatory compliance. However, the benefits of passive motion therapy in preventing complications and enhancing recovery are likely to outweigh these risks. Strategic implications for market players involve fostering collaborations with technology firms, investing in direct-to-consumer models for home-based care, and expanding presence in high-growth regions like Asia Pacific and Latin America. The market will also see a greater emphasis on data-driven rehabilitation, offering personalized treatment plans and improved patient monitoring, ultimately shaping a more efficient and effective recovery landscape.